Last Updated:
Monday, November 29, 2021
3:05 AM
Germany
BioNTech
BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches.
Stock Quote
BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches.
Newsroom
May 5, 2020
Pfizer, BioNTech begin coronavirus vaccine trial in humans | Fox News
April 29, 2020
Pfizer, BioNTech complete dosing for first cohort of COVID-19 ...
April 29, 2020
Pfizer, BioNTech finish dosing in COVID-19 vax test; emergency use ...
April 22, 2020
BioNTech Gets Green Light to Start Coronavirus Vaccine Trials in ...
April 22, 2020
BioNTech and Pfizer get German nod for Covid-19 vaccine trial
April 9, 2020
BioNTech and Pfizer release details of COVID-19 vaccine ...
April 1, 2020
mRNA Vaccines – Trials Line Up Against Coronavirus
Stock Quote
Vaccine
Treatment
Testing
Stats
Infographics
Menu
Vaccine
Treatment
Testing
Stats
Infographics
